|
May 7
|
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2024 Earnings Call Transcript
|
|
May 6
|
Jazz (JAZZ) International Revenue Performance Explored
|
|
May 3
|
Jazz Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations
|
|
May 1
|
Jazz (JAZZ) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
May 1
|
Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference
|
|
May 1
|
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
|
|
Apr 25
|
Ardelyx (ARDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
Apr 24
|
Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024
|
|
Apr 24
|
Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
|
Apr 24
|
3 No-Brainer Stocks to Buy With $300 Right Now
|
|
Apr 22
|
A Closer Look At Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) Uninspiring ROE
|
|
Apr 17
|
Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024
|
|
Apr 10
|
Jazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology Annual Meeting
|
|
Apr 5
|
Pharma Stock Roundup: AZN Voydeya Gets FDA Nod, MRK KRAS Inhibitor Enters Phase III
|
|
Apr 4
|
Following the Money Trail: Where are Hedge Funds Investing?
|
|
Apr 2
|
Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer
|
|
Mar 29
|
Why Is Jazz (JAZZ) Up 1.3% Since Last Earnings Report?
|
|
Mar 28
|
Cancer and the Combination Approach
|
|
Mar 20
|
Jazz Pharmaceuticals Celebrates International Women’s Day
|
|
Mar 18
|
20 States with the Cheapest Weed in America
|